Impact of arterial hypertension on dialytic methods in Cuba

Authors

  • Jorge Francisco Pérez-Oliva Díaz Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana
  • Miguel Almaguer Herrera Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana
  • Raúl Herrera Valdés Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana
  • Raquel Pérez Campa Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana
  • Alexander Mármol Sóñora Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana https://orcid.org/0000-0003-2144-6004

Keywords:

incident patients, renal replacement therapy, chronic kidney disease, arterial hypertension/vascular renal disease, cardiovascular mortality, cerebrovascular mortality, prevention.

Abstract

Introduction: High blood pressure is an important and recognized cause of initiation of dialysis methods in patients and of cardio-cerebrovascular morbidity and mortality.

Objective: To show the impact of high blood pressure on dialysis methods in Cuba as management of risk factors for chronic kidney disease.

Methods: A 20-year longitudinal study was carried out (from 2002 to 2022) of patients who started dialytic renal replacement therapy in Nephrology Services throughout the country. The variables analyzed (all in adult patients) were: gender, age (years) and etiological causes (including high blood pressure).

Results: High blood pressure/renal vascular disease was the main cause that led to the initiation of dialysis in adult patients, and ranged from 32.2 to 38.4%, followed by diabetic kidney disease and glomerulopathies. The male sex predominated. The average age of life increased from 37 years in 2003 to 58.1 years in 2022. The main causes of death were cardiac (29–42%) followed by infectious (35.3–25.9%) and in third position the cerebrovascular (8-12%). Heart and cerebrovascular diseases were the causes of the increase in deaths in 2022 (38.87-49%)

Conclusions: The need to carry out strict control of arterial hypertension as an isolated risk factor, and its impact on mortality, was demonstrated by starting patients on dialytic methods and its effect on cardio-cerebrovascular mortality and for the effective management of the factors. risk of chronic kidney disease

 

Downloads

Download data is not yet available.

Author Biography

Jorge Francisco Pérez-Oliva Díaz, Universidad de Ciencias Médicas de la Habana. Instituto de Nefrología Dr. Abelardo Buch López. La Habana

Jefe del Departamento Coordinados del Programa "Enfermedad Renal, Dialisis t Trasplante Renal" Presidente Sociedad Cubana de Nefrología

References

Radhakrishnan J, Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; [acceso 09/08/2023];67:2089–2100. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15882252/

Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;96(5):1048-50. DOI: https://doi.org/10.1093/ndt/gfz174

Fresenius Medical Care ESRD (End Stage Kidney Disease) Patients in 2021 A Global Perspective. 2021 [acceso 09/08/2023];2(4):604–7. Disponible en: https://www.freseniusmedicalcare.com/en/news/fresenius-medical-care-publishes-2021-global-annual-medical-report

Jager K J, Simon D.S. Fraser S.D.S. The ascending rank of chronic kidney disease in the global burden of disease study. Nephrol Dial Transplant. 2017;32:i121-8. DOI: https://doi.org/10.1093/ndt/gfw330

Csba PK. Edidemiology of chronic kidney disease: an update 2022 Kidney Intern. Supp. 2022;12,7-11 DOI: https://doi.org/10.1016/j.kisu.2021.11.03

Kim CS, Choi HS, Bae EH, Kim SW, Ma SK. Optimal blood pressure target and measurement in patients with chronic kidney disease. Korean J Intern Med. 2019;34(6):1181-7. DOI: https://doi.org/10.3904/kjim.2019.164

Herrera Valdés R, Almaguer López M, Chipi Cabrera JA, Pérez-Oliva Díaz JF, Landrove Rodríguez O, Mármol Sóñora A. Prevalence and incidence of chronic kidney disease in Cuba. Clin Nephrol. 2020;93(1):68-714. DOI: https://doi.org/10.5414/CNP92S111

Pérez Caballero MD, Delfín M, Álvarez L, León JL, Dueñas A, Alfonzo JP, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensión arterial 2017. Rev. Cubana Med. 2017 [acceso 09/08/2023]:11(3)424-33. Disponible en: http://scielo.sld.cu/pdf/rhcm/v11n3/rhcm14312.pdf

Chen TK, Knicely DH, Grams ME,Chen TK. Chronic Kidney Disease Diagnosis and Manegement: a review. JAMA. 2018;1;322(13):1294-304. DOI: https://doi.org/10.1001/jama.2019.14745

Ruzicka M, QuinnMcFarlane P, Hemelgarm B, Ramesh GV, Feber J, Nesrallah G et al Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for the management of blood pressure in CKD Am. J Kidney Dis. 2014;63(6):869-87. DOI: https://doi.org/10.1053/j.ajkd.2014.03.003

Go DS, Kim SH, Park J, Ryu DR, Lee HJ, Jo MW. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea. Nephrology (Carlton) 2019;24:56-64. DOI: https://doi.org/10.1111/nep.13203

Abbasi M, Chertow G, Hall Y. End-stage Renal Disease. Am Fam Physician. 2010 [acceso 09/08/2023];15;82(12):1512. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21166372/

SecciaTM, Caroccia B, Calò L. A. hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms. Journal of Hypertension, 2017;35(2),205-12. DOI: https://doi.org/10.1097/HJH.000000000000117

Online version of ISN Global Kidney Health Atlas: International Society of Nephrology, 2017 [acceso 09/08/2023]. Disponible en: https://www.theisn.org/wp-content/uploads/2021/05/GKDAtlas_2017_FinalVersion-1.pdf

Thurlow J, Joshi M, Yan G, Norris KC. Global Epidemiology of ESRD and Disparities in Kidney Replacement Therapy. F Nephrol. 2021;52(2):98-107 DOI: https://doi.org/10.1159/000514550

United States Renal Data System. 2022. USRDS:2022 Annual Data Report. Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022. [acceso 09/08/2023]. Disponible en: https://usrds-adr.niddk.nih.gov/2022/

González-Bedata MC, Rosa-Diez G. Registro Latinoamericano de Diálisis y Trasplante Renal. años 2020-2021. Reporte 2021.[acceso 09/08/2023]. Disponible en: https://slanh.net/registros/

Jha V, García-García G, Iseki K, Li Z, Naicker S, Plattner B, et,al. Chronic kidney disease: Global dimension and perspectives. The Lancet. 2013;382(9888),260-72. DOI: https://doi.org/10.1016/

Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD et al International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology. 2019;24(10):1064-76. DOI: https://doi.org/10.1111/nep.13531

Kim CS, Choi HS, Bae EH, Kim SW, Ma SK. Optimal blood pressure target and measurement in patients with chronic kidney disease. Korean J InternMed. 2019;34(6):1181-7. DOI: https://doi.org/10.3904/kjim.2019.164

Go AS, Chertow GM, Fan D, McCulloch ChE, Hsu C. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. New EngJ Medic. 2004;351:1296-305. DOI: https://doi.org/10.1056/NEJMoa041031

Keith DS, Nichols GA, Guillon CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Inter Med. 2004;164(6)659-63. DOI: https://doi.org/10.1001/archinte.164.6-659NEJMoa041031

Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K, et al. Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From KDIGO Controversies. STROKE 2021;52(7):E328-46. DOI: https://doi.org/10.1161/STROKEAHA.120.029680

Ducloux D, Legendre M, Bamoulid J, Saas PH, Courivaud C. End Stage Renal Disease Related Immune senescence: is Rejuvenation of the Immune System a Therapeutic Goal? National Kideny Foundation. eGFR (electronic Glomerular Funtion Rate) Calculator. Disponible en: https://www.kidney.org/professionals/KDOQI/gfr_calculator

Downloads

Published

2024-02-13

How to Cite

1.
Pérez-Oliva Díaz JF, Almaguer Herrera M, Herrera Valdés R, Pérez Campa R, Mármol Sóñora A. Impact of arterial hypertension on dialytic methods in Cuba. Acta Médica [Internet]. 2024 Feb. 13 [cited 2025 Apr. 1];24(4). Available from: https://revactamedica.sld.cu/index.php/act/article/view/411

Issue

Vol. 24 No. 4 (2023): octubre-diciembre

Section

Artículos originales

License

Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:

  1. Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
  2. Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
  3. Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).